Vistagen

Vistagen company information, Employees & Contact Information

Explore related pages

Vistagen email format Vistagen management contacts

Related company profiles:

Headquartered in South San Francisco, CA, Vistagen (Nasdaq: VTGN) is a late clinical-stage company leveraging its pioneering neuroscience and deep understanding of nose-to-brain neurocircuitry to develop and commercialize a broad and diverse pipeline of intranasal product candidates called pherines. Each pherine product candidate in Vistagen’s neuroscience pipeline is designed to rapidly activate olfactory system and brain neurocircuitry to achieve desired therapeutic benefits and differentiated safety without requiring systemic absorption or binding to neurons in the brain. Vistagen’s neuroscience pipeline also includes an oral prodrug, AV-101, with potential to impact certain neurological conditions involving the NMDA receptor. Vistagen is passionate about developing transformative treatment options to improve the lives of individuals underserved by the current standard of care for multiple highly prevalent disorders, including social anxiety disorder, major depressive disorder, and vasomotor symptoms (hot flashes) associated with menopause. Connect at www.vistagen.com.

Company Details

Employees
68
Founded
-
Address
343 Allerton Ave, South San Francisco,california 94080,united States
Industry
Pharmaceutical Manufacturing
NAICS
Pharmaceutical and Medicine Manufacturing
Medicinal and Botanical Manufacturing
Pharmaceutical Preparation Manufacturing
In-Vitro Diagnostic Substance Manufacturing
Biological Product (except Diagnostic) Manufacturing
Website
vistagen.com
Keywords
Representative jobs.
HQ
South San Francisco, California
Competitors
atai Life Sciences, 3T Biosciences, Axsome Therapeutics, Inc., Compass Pathways, Relmada Therapeutics, Inc, Freedom Biosciences, Mediar Therapeutics, Sutro Biopharma, Inc., Alto Neuroscience, MindMed.
Looking for a particular Vistagen employee's phone or email?

Vistagen Questions

News

Vistagen to Present at The Menopause Society 2025 Annual Meeting - Business Wire

Vistagen to Present at The Menopause Society 2025 Annual Meeting Business Wire

Vistagen Honored for Outstanding Workplace Culture and Mental Health Leadership - Yahoo Finance

Vistagen Honored for Outstanding Workplace Culture and Mental Health Leadership Yahoo Finance

Vistagen Reports Fiscal Year 2026 First Quarter Financial Results and Corporate Update - Business Wire

Vistagen Reports Fiscal Year 2026 First Quarter Financial Results and Corporate Update Business Wire

Vistagen to Present at the TD Cowen 5th Annual Novel Mechanisms in Neuropsychiatry & Epilepsy Summit - FinancialContent

Vistagen to Present at the TD Cowen 5th Annual Novel Mechanisms in Neuropsychiatry & Epilepsy Summit FinancialContent

VistaGen Therapeutics Announces Exercise and Closing of Underwriters' Over-allotment Option in Underwritten Public Offering - PR Newswire

VistaGen Therapeutics Announces Exercise and Closing of Underwriters' Over-allotment Option in Underwritten Public Offering PR Newswire

Topline results show fasedienol nasal spray reduces symptoms in social anxiety disorder - Healio

Topline results show fasedienol nasal spray reduces symptoms in social anxiety disorder Healio

Vistagen Initiates Fasedienol Repeat Dose Study for the Acute Treatment of Social Anxiety Disorder - Yahoo Finance

Vistagen Initiates Fasedienol Repeat Dose Study for the Acute Treatment of Social Anxiety Disorder Yahoo Finance

VistaGen Therapeutics Announces Closing of $100 Million Underwritten Public Offering - GlobeNewswire

VistaGen Therapeutics Announces Closing of $100 Million Underwritten Public Offering GlobeNewswire

Vistagen, The Goldie Hawn Foundation, and MindUP Students to Ring Nasdaq Closing Bell on World Mental Health Day - Stock Titan

Vistagen, The Goldie Hawn Foundation, and MindUP Students to Ring Nasdaq Closing Bell on World Mental Health Day Stock Titan

VistaGen Stock Soars 1,000% After Phase III Social Anxiety Win - BioSpace

VistaGen Stock Soars 1,000% After Phase III Social Anxiety Win BioSpace

VistaGen finds open-label success with social anxiety nasal spray, but PALISADE pivotal trial remains iced - Fierce Biotech

VistaGen finds open-label success with social anxiety nasal spray, but PALISADE pivotal trial remains iced Fierce Biotech

Vistagen: Pherine Candidate Proof Of Concept Continues With Fifth Indication (NASDAQ:VTGN) - Seeking Alpha

Vistagen: Pherine Candidate Proof Of Concept Continues With Fifth Indication (NASDAQ:VTGN) Seeking Alpha

Vistagen on Track to Deliver Topline Data From Fasedienol PALISADE-3 Phase 3 Trial for Acute Treatment of Social Anxiety Disorder in the Fourth Quarter of This Year - Business Wire

Vistagen on Track to Deliver Topline Data From Fasedienol PALISADE-3 Phase 3 Trial for Acute Treatment of Social Anxiety Disorder in the Fourth Quarter of This Year Business Wire

Vistagen completes acquisition of Pherin Pharmaceuticals - Healio

Vistagen completes acquisition of Pherin Pharmaceuticals Healio

Vistagen to Report Fiscal Year 2025 Financial Results and Host Corporate Update Conference Call on June 17, 2025 - Business Wire

Vistagen to Report Fiscal Year 2025 Financial Results and Host Corporate Update Conference Call on June 17, 2025 Business Wire

Is Vistagen Therapeutics (NASDAQ:VTGN) In A Good Position To Invest In Growth? - Yahoo Finance

Is Vistagen Therapeutics (NASDAQ:VTGN) In A Good Position To Invest In Growth? Yahoo Finance

Vistagen Announces Pricing of $100 Million Underwritten Offering - Business Wire

Vistagen Announces Pricing of $100 Million Underwritten Offering Business Wire

Intranasal Therapy Fast-Tracked for Social Anxiety Disorder - Medical Professionals Reference

Intranasal Therapy Fast-Tracked for Social Anxiety Disorder Medical Professionals Reference

Investigational Nasal Spray May Improve Symptoms in Cancer Cachexia - Oncology Nursing News

Investigational Nasal Spray May Improve Symptoms in Cancer Cachexia Oncology Nursing News

Vistagen Could Run Up Ahead Of Phase 3 Results In Social Anxiety Disorder - Seeking Alpha

Vistagen Could Run Up Ahead Of Phase 3 Results In Social Anxiety Disorder Seeking Alpha

Vistagen's stock soars 1,272% after social anxiety nasal spray hits phase 3 goals - Fierce Biotech

Vistagen's stock soars 1,272% after social anxiety nasal spray hits phase 3 goals Fierce Biotech

VistaGen can't puff out phase 3 success for social anxiety nasal spray - Fierce Biotech

VistaGen can't puff out phase 3 success for social anxiety nasal spray Fierce Biotech

Nasal Spray Fasedienol Provides Rapid Social Anxiety Benefit in Phase 3 Trial - HCPLive

Nasal Spray Fasedienol Provides Rapid Social Anxiety Benefit in Phase 3 Trial HCPLive

Nasal Spray Demonstrates Ability to Reduce Social Anxiety Disorder Symptoms - Psychiatric Times

Nasal Spray Demonstrates Ability to Reduce Social Anxiety Disorder Symptoms Psychiatric Times

VistaGen’s Nasal Spray for Social Anxiety Disorder Falls Short in Phase III Trial - BioSpace

VistaGen’s Nasal Spray for Social Anxiety Disorder Falls Short in Phase III Trial BioSpace

A Potential Benzodiazepine Replacement - Psychiatric Times

A Potential Benzodiazepine Replacement Psychiatric Times

VistaGen Therapeutics (VTGN) Stock Price, News & Analysis - MarketBeat

VistaGen Therapeutics (VTGN) Stock Price, News & Analysis MarketBeat

Earnings call: Vistagen reports on clinical updates and financial health By Investing.com - Investing.com UK

Earnings call: Vistagen reports on clinical updates and financial health By Investing.com Investing.com UK

Sprouting a career in regenerative medicine - Science | AAAS

Sprouting a career in regenerative medicine Science | AAAS

Companies like Vistagen

Alto Neuroscience logo - Similar company to Vistagen

Alto Neuroscience

77
Axsome Therapeutics, Inc. logo - Similar company to Vistagen

Axsome Therapeutics,...

809
atai Life Sciences logo - Similar company to Vistagen

Atai Life Sciences

76
3T Biosciences logo - Similar company to Vistagen

3T Biosciences

28
Sutro Biopharma, Inc. logo - Similar company to Vistagen

Sutro Biopharma, Inc.

303
Relmada Therapeutics, Inc logo - Similar company to Vistagen

Relmada Therapeutics...

32
MindMed logo - Similar company to Vistagen

Mindmed

115
Freedom Biosciences logo - Similar company to Vistagen

Freedom Biosciences

5
Mediar Therapeutics logo - Similar company to Vistagen

Mediar Therapeutics

52
Compass Pathways logo - Similar company to Vistagen

Compass Pathways

219

Top Vistagen Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant